Clinical Trials Browser

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05263180 2023-10-18

A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Phase 1 Unknown

30 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05267899 2023-09-26

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Phase 1 Unknown

24 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06047431 2023-09-21

A Study of QL1706H in Patients With Advanced Solid Tumors

Phase 1 Unknown

150 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06008366 2023-09-13

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

Phase 1/2 Unknown

281 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06008379 2023-09-13

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

164 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06019013 2023-08-31

A Study of QLF3108 in Participants With Advanced Solid Tumor

Phase 1 Unknown

78 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06015269 2023-08-29

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Phase 1 Unknown

200 enrolled

Other solid neoplasm

Solid Tumor

NCT05509985 2023-08-14

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

Phase 1 Unknown

100 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04965220 2023-08-09

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

220 enrolled

Other solid neoplasm

Solid Tumor

NCT05360381 2023-08-08

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

82 enrolled

Other solid neoplasmThoracic

Locally Advanced or Metastatic Solid Tumors

NCT05840835 2023-08-08

IMMINENT-01

Phase 1/2 Unknown

60 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05884801 2023-08-01

Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

148 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04856150 2023-07-27

A Study of Q-1802 in Patients With Advanced Solid Tumors

Phase 1 Unknown

66 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05021367 2023-07-24

A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor

Phase 1 Unknown

164 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05396339 2023-07-19

A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.

Phase 1/2 Unknown

120 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT05173805 2023-07-18

Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation

Phase 1/2 Unknown

150 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05944185 2023-07-14

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

Phase 1/2 Unknown

42 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05941936 2023-07-12

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

5 enrolled

Other solid neoplasm

Solid Tumor

NCT05934539 2023-07-07

ALG.APV-527 First-in-human Study

Phase 1/2 Unknown

56 enrolled

Other solid neoplasm

Solid Tumor

NCT05821595 2023-06-27

JYB1907 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

30 enrolled

Other solid neoplasm

Solid Tumor

NCT05911984 2023-06-22

A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors

Phase 1 Unknown

27 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT05869240 2023-06-06

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1/2 Unknown

388 enrolled

Other solid neoplasm

Solid Tumor

NCT05794477 2023-06-02

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

132 enrolled

Other solid neoplasm

Advanced Solid Tumor